Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

Q: What does CUSIP 89532M101 represent in this 13F holders report?

CUSIP 89532M101 is the security identifier for TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q1 2023?

35 institutional investors reported TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q1 2023. Use the holders table for investor-level position and value details.

CUSIP: 89532M101

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 143,562,667
Total 13F shares: 43,462,507
Share change: +276,560
Total reported value: $80,405,139
Put/Call ratio: 4309%
Price per share: $1.85
Number of holders: 35
Value change: +$498,873
Number of buys: 14
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 89532M101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	7.9%	11,373,174	$21,950,226	—	31 Dec 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	4.6%	6,663,590	$12,860,729	—	31 Dec 2022	13F
Fairmount Funds Management LLC	13F	Company	4%	5,696,515	$10,994,274	—	31 Dec 2022	13F
Rubric Capital Management LP	13F	Company	4%	5,684,420	$10,970,931	—	31 Dec 2022	13F
VIKING GLOBAL INVESTORS LP	13F	Company	3.1%	4,400,000	$8,492,000	—	31 Dec 2022	13F
TPG GP A, LLC	3/4/5	Former 10% Owner	— class O/S missing	3,824,883	$7,726,264	—	01 Jul 2022	3/4/5
VR Adviser, LLC	13F	Company	2.1%	3,050,022	$5,886,542	—	31 Dec 2022	13F
MAI Capital Management	13F	Company	1.2%	1,720,676	$3,320,905	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	1%	1,439,593	$2,778,414	—	31 Dec 2022	13F
Peter W. Sonsini	3/4/5	10%+ Owner	— mixed-class rows	3,948,948 mixed-class rows	$1,916,875	—	11 Apr 2022	3/4/5
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.53%	767,631	$1,481,528	—	31 Dec 2022	13F
Opaleye Management Inc.	13F	Company	0.34%	485,000	$936,050	—	31 Dec 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.22%	318,000	$614,000	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	211,547	$408,000	—	31 Dec 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	208,400	$402,212	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.11%	157,624	$304,000	—	31 Dec 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	0.11%	152,300	$293,939	—	31 Dec 2022	13F
Tejara Capital Ltd	13F	Company	0.1%	149,958	$289,419	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	0.07%	99,542	$192,116	—	31 Dec 2022	13F
WealthTrust Axiom LLC	13F	Company	0.07%	93,500	$180,455	—	31 Dec 2022	13F
J. Goldman & Co LP	13F	Company	0.06%	89,188	$172,133	—	31 Dec 2022	13F
INNOVIS ASSET MANAGEMENT LLC	13F	Company	0.06%	87,453	$168,784	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	0.06%	80,771	$155,887	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.04%	54,115	$104,442	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	44,216	$85,337	—	31 Dec 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	28,653	$55,300	—	31 Dec 2022	13F
UNITED BANK	13F	Company	0.02%	28,450	$54,909	—	31 Dec 2022	13F
Atom Investors LP	13F	Company	0.02%	25,376	$48,976	—	31 Dec 2022	13F
BAILARD, INC.	13F	Company	0.01%	21,200	$40,916	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	0.01%	14,098	$27,209	—	31 Dec 2022	13F
Virtu Financial LLC	13F	Company	0.01%	13,995	$27,000	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	12,557	$24,235	—	31 Dec 2022	13F
LPL Financial LLC	13F	Company	0.01%	10,000	$19,300	—	31 Dec 2022	13F
UBS Group AG	13F	Company	0%	3,091	$5,966	—	31 Dec 2022	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0%	500	$965	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	0%	439	$848	—	31 Dec 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	261	$504	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	92	$178	—	31 Dec 2022	13F
William P. Forbes	3/4/5	Chief Development Officer	— mixed-class rows	185,500 mixed-class rows	—	—	29 Jun 2022	3/4/5

Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q1 2023

As of 31 Mar 2023, Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,462,507 shares. The largest 10 holders included NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Fairmount Funds Management LLC, Rubric Capital Management LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, MAI Capital Management, VANGUARD GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, and Opaleye Management Inc.. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

Q1 2023 holders

Holder diff

-1

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.